Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Circulating Tumor Cells Global Market by Material & Data Validation, Analysis and Forecast 2022

Tuesday, February 28, 2017 12:56
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Global Circulating Tumor Cells Market is accounted for $4.41 billion in 2015 and is expected to reach $17.96 billion by 2022 growing at a CAGR of 19.2 % from 2015 to 2022. The rising demand for high Benefit-Cost Ratio (BCR) associated with CTCs prognostic technology is the major factor boosting the market growth. Furthermore, advancements in biomedical imaging and bioengineering technology are some of the key factors driving the market. However, high cost associated with the diagnosing and reluctance among people towards adopting highly developed prognostic technologies inhibit the market growth. The recent trends in global Circulating Tumor Cells are strengthening distribution network of CTCs prognostic technologies in emerging economies and the technical advancement of CTCs-based customized medicines.

Tumor cell detection is the foremost product segment primarily due to the advantages related with therapeutic monitoring and high procedure prices. North America region is expected to witness highest growth rate during the forecast period due to increasing demand in number of research projects. In addition, the U.S. Government also supports research by funding various institutes, which grant research funds. 

 For more information http://www.reportsweb.com/circulating-tumor-cells-global-market-outlook-2015-2022

Some of the key players in the market include Adnagen AG, Advanced Cell Diagnostics, Apocell, Aviva Biosciences, Biocep Ltd., Biocept Inc., Biofluidica, Canopus Biosciences, CellTraffix Inc., Clearbridge BioMedics, Creatv Microtech Inc., Cynvenio Biosystems Inc. , Epic Biosciences, Fluxion Biosciences., Greiner Bio-One GmbH, Ikonisys Inc., IV Diagnostics Inc., Janssen Diagnostics, Miltenyi Biotech and Nanostring Technologies Inc.

Technologies Covered:
- Tumor Cell Enrichment
- Filtration
- Centrifugation
- Immunological and Immunomagnetic
- Tumor Cell Detection
- Molecular
- Optical

Applications Covered:
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Other Applications

Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK 
- Spain 
- Rest of Europe 
- Asia Pacific
- Japan 
- China 
- India 
- Australia 
- New Zealand 
- Rest of Asia Pacific 
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216357/sample

9 Company Profiling 
9.1 Adnagen AG 
9.2 Advanced Cell Diagnostics 
9.3 Apocell 
9.4 Aviva Biosciences 
9.5 Biocep Ltd. 
9.6 Biocept Inc. 
9.7 Biofluidica 
9.8 Canopus Biosciences 
9.9 CellTraffix Inc. 
9.10 Clearbridge BioMedics 
9.11 Creatv Microtech Inc. 
9.12 Cynvenio Biosystems Inc. 
9.13 Epic Biosciences 
9.14 Fluxion Biosciences. 
9.15 Greiner Bio-One GmbH 
9.16 Ikonisys Inc. 
9.17 IV Diagnostics Inc. 
9.18 Janssen Diagnostics 
9.19 Miltenyi Biotech 
9.20 Nanostring Technologies Inc. 

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216357/buying

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.